Compliance Monitoring
Compliance Monitoring is designed to manage federal and state compliance across all aspects of the business and is tailored to the Client’s specific business model and product portfolio.
Compliance Monitoring Services
Determine license and compliance requirements in each state via blinded surveys (board communication), legal research, and ancillary research.
The requirements, with specific action items, shall be determined specific to the Client’s various business models, product portfolio, and other nuances of operations. Compliance requirements provided will also consider changes in internal operations and federal and state regulations.
Monitored Compliance Requirements Include:
-
- Federal (DSCSA, DEA, FDA); and
- State (Licensing, Self-Inspection, Opioid Tax, Price Transparency, PSE Reporting, CS Reporting, Drug Takeback, state-controlled substances).
We’d like to hear from you
Our Solutions
NavigateSOM
Our Suspicious Order Monitoring (SOM) software helps pharmaceutical manufacturers and distributors make sure that they follow DEA requirements. Federal and state agencies are increasing investigation into the players of the pharmaceutical supply chain.
LighthouseAI
LighthouseAI leverages AI-technology to perform instant compliance assessments across all state and federal jurisdictions, identifying requirements specific to your facility, then automating regulatory surveillance for ongoing protection.
State Licensing
Keeping track of each state’s licensing requirements and processes can become an expensive and lengthy process. Let our expert consultants manage your state licensing process from start to finish.
NABP Drug Distributor Accreditation
Looking to earn NABP Drug Distributor Accreditation (formerly VAWD® Accreditation) for your business but not sure where to turn? Let us guide you through the accreditation process.
Pharmacy Consulting
When you choose Pharma Solutions for pharmacy consulting, your unique business requirements are in capable hands. As leading industry experts, we’ve got you covered with new pharmacy startup...
Recent Articles
FDA Authorizes Florida’s Drug Importation Program
FDA Warning on Xylazine: Mitigating Human Risk
Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know
Important Updates from the Alabama Board of Pharmacy on Facility Applications and Renewals
FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements
A Comprehensive Guide to Pharmaceutical State Licensing Renewals
Kentucky Has Filed Amendments to Regulations and/or New Regulations
New FDA Clarification Allows Wholesale by 503B Facilities to 503A Pharmacies
Navigating the Prescription Drug Reform Act: A New Landscape for Drug Manufacturers in Florida
